WO2025068987 - A METHOD OF PRODUCING A KUMAMOLISIN-AS POLYPEPTIDE
National phase entry is expected:
Publication Number
WO/2025/068987
Publication Date
03.04.2025
International Application No.
PCT/IB2024/059493
International Filing Date
27.09.2024
Title **
[English]
A METHOD OF PRODUCING A KUMAMOLISIN-AS POLYPEPTIDE
[French]
PROCÉDÉ DE PRODUCTION D'UN POLYPEPTIDE KUMAMOLISIN-AS
Applicants **
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Inventors
FUHRMANN, Bernd
FIEDLER, Christian
MUNOZ, Ivanna
SCHWARZ, Karin
ZOECHLING, Oliver
BRANDIS, Janina
CHEN, Kuan-Wei
PALIGE, Michael
Priority Data
63/586,317
28.09.2023
US
63/673,262
19.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3765 | |
| EPO | Filing, Examination, Granting | 43842 | |
| Japan | Filing, Examination, Granting | 3668 | |
| South Korea | Filing, Examination, Granting | 5047 | |
| USA | Filing, Examination, Granting | 13940 |
Total:
70,262
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure is directed to methods of producing Kuma polypeptides. The method of producing Kuma polypeptides can comprise heat treatment and purification by calcium precipitation. The present disclosure is also directed to methods of producing Kuma polypeptides, wherein the Kuma polypeptide comprises a polypeptide of Kuma062.[French]
La présente divulgation concerne des procédés de production de polypeptides Kuma. Le procédé de production de polypeptides Kuma peut comprendre un traitement thermique et une purification par précipitation de calcium. La présente divulgation concerne également des procédés de production de polypeptides Kuma, le polypeptide Kuma comprenant un polypeptide de Kuma062.